AzTrials
AzTrials

Leukemia Acute Lymphoid Leukemia (ALL)lifestyleNCT07162558

The Effect of Child-centered Empowerment on Lifestyle of Leukemia Patients

A study testing Child-Centered Empowerment Intervention in people with Leukemia Acute Lymphoid Leukemia (ALL) and Lifestyle Intervention for at Least 1 Month, run by Near East University, Turkey at 1 site in Cyprus.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized clinical trial aimed to evaluate the effectiveness of a child-centered empowerment model in improving the lifestyle of children with leukemia. The study focused on whether structured empowerment interventions could significantly enhance daily habits and overall well-being in pediatric oncology… Read more about this study

Who is it for?
Ages 7 to 13 years
What is being tested?
Child-Centered Empowerment Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
46 participants
Where
1 siteCyprus
Study dates
2 Sep 2024to 30 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 13 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children aged 7-13 years diagnosed with leukemia and admitted to the pediatric oncology clinic.
  • Children and parents willing to participate in the study and provide written informed consent (parents) and assent (children).
  • No reported history of specific mental disorders as declared by parents.

Who cannot join

  • Inconsistent participation in empowerment sessions (e.g., missing scheduled intervention sessions).
  • Withdrawal from the study by the child or family at any time. Any condition preventing the child from completing questionnaires or participating in group discussions.

Trial locations and contacts

1 site in 1 country.

Cyprus1 site
  • Near East University

    Nicosia, KKTC (Turkish Republic of Northern Cyprus), 99138

Other trials in Cyprus

About this study

This randomized clinical trial aimed to evaluate the effectiveness of a child-centered empowerment model in improving the lifestyle of children with leukemia. The study focused on whether structured empowerment interventions could significantly enhance daily habits and overall well-being in pediatric oncology patients. The main research questions were:

Does the child-centered empowerment model improve the lifestyle of children with leukemia? Can this complementary and non-invasive method be considered a viable approach for supporting pediatric care?

Participants (N = 46) aged 7-13 years were randomly assigned to either the intervention group, which received empowerment training in four dimensions (perceived threat, self-efficacy, educational participation, and evaluation), or the control group, which received routine care. Pre- and post-intervention assessments were conducted using a validated lifestyle questionnaire measuring nutrition, sleep, physical activity, physical health, and stress.

Read the detailed description

Study Title:

The Effect of Child-Centered Empowerment on the Lifestyle of Children with Leukemia

Study Purpose:

The aim of this study was to investigate the efficacy of a child-centered empowerment model in improving the lifestyle of pediatric patients with leukemia. The intervention was designed to strengthen coping abilities, promote healthier daily habits, and enhance overall well-being, in line with holistic and family-centered nursing principles. The study was conducted as a double-blind randomized clinical trial.

Sample Size Determination:

The statistical population of this study included school-aged children (7-13 years) diagnosed with leukemia and admitted to a pediatric oncology clinic in Tehran. A total of 46 eligible children who met the inclusion criteria were enrolled using purposive sampling. Participants were randomly assigned into experimental (n = 23) and control groups (n = 23).

Sample size was determined using the mean comparison formula based on a similar study (Shoghi et al., 2019), with Type I error set at 0.05 and power at 80%. The required sample size was calculated as 19 per group, which was increased to 23 per group to account for an anticipated 20% dropout rate.

To minimize bias, a double-blind design was used. The researcher responsible for data collection was unaware of group allocations, and the statistician analyzing the data processed them under masked labels (x1 and x2).

Tools of Data Collection:

  1. Demographic questionnaire: Collected background information including age, gender, weight, height, knowledge of illness, and place of living.
  2. Lifestyle questionnaire: A validated 38-item tool assessing five domains-nutrition, sleep, physical activity, physical health, and stress. Each item was rated on a 4-point Likert scale ("often" to "never"), with total scores ranging from 38 to 114, categorized as unfavorable (38-63), average (64-88), and favorable (89-114). Validity and reliability were confirmed in prior studies (Farahani et al., 2018).
  3. Pre- and post-intervention lifestyle assessment: Completed by all participants before and one month after the intervention period.

Intervention:

Experimental Group:

Children and their families participated in a structured child-centered empowerment program consisting of five sessions (30 minutes each) delivered by a trained pediatric nursing expert. The intervention included four dimensions:

Perceived Threat: Increasing awareness of the illness, complications, and treatment process through group discussions.

Self-Efficacy: Practicing problem-solving and self-management techniques to strengthen self-belief and self-control.

Educational Participation: Children were provided with educational cards to share learned content with family members, reinforcing knowledge and responsibility.

Evaluation: Ongoing assessment of understanding and active involvement through follow-up questions after each session.

Instructional materials were also shared via social media (WhatsApp) to enhance family engagement.

Control Group:

Children in the control group received routine care only, with no empowerment training.

Implementation Phase:

The study was conducted in the pediatric oncology clinic in Tehran. After recruitment, children were randomly allocated into intervention or control groups based on admission order (even-numbered admissions to intervention, odd-numbered to control). All participants completed demographic and lifestyle questionnaires before the intervention, and lifestyle reassessment was conducted one month after program completion.

Ethics approval The research received ethical clearance from the Near East University Ethics Review Board with the approval number NUE/2023/117-1776. The initiative closely followed the ethical standards established by the Council of Ethics and was carried out in complete accordance with the principles outlined in the Declaration of Helsinki (1964).

Statistical Analysis:

All data were analyzed using SPSS version 25. The Kolmogorov-Smirnov test was applied to check data normality. Descriptive statistics (mean, standard deviation, and frequencies) were used for demographic data. Inferential statistics included:

Paired t-test to compare pre- and post-intervention scores within each group Independent t-test to compare differences between experimental and control groups Chi-square test to analyze categorical variables A significance level of P < 0.05 was considered statistically significant.

Being tested
Child-Centered Empowerment Intervention
Keywords
Empowerment Model, Quality of Life, Pediatric Nursing, Children
Medical subject headings
Precursor Cell Lymphoblastic Leukemia-Lymphoma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Child-Centered Empowerment InterventionBehavioural

    Participants in this group receive the child-centered empowerment program, a structured behavioral intervention designed to enhance coping skills, promote self-efficacy, and improve lifestyle in children with leukemia. The program is based on four dimensions of empowerment:

    Perceived Threat: Increasing awareness of illness, its complications, and the treatment process through group discussions.

    Self-Efficacy: Practicing problem-solving and self-management techniques to strengthen self-belief, self-control, and confidence in handling illness-related challenges.

    Educational Participation: Children receive educational cards at the end of each session and are encouraged to share the learned content with family members to reinforce responsibility and engagement.

    Evaluation: Continuous follow-up and assessment of learning after each session to ensure understanding and active participation.

Study groups in NCT07162558
Study groupRoleWhat they receive
Child-Centered EmpowermentExperimentalBehavioral: Child-Centered Empowerment Intervention Participants in this group receive the child-centered empowerment program, a structured behavioral intervention designed to enhance coping skills, promote self-efficacy, and improve lifestyle in children with leukemia. The program is based on four dimensions of empowerment: Perceived Threat: Increasing awareness of illness, its complications, and the treatment process through group discussions. Self-Efficacy: Practicing problem-solving and self-management techniques to strengthen self-belief, self-control, and confidence in handling illness-related challenges. Educational Participation: Children receive educational cards at the end of each session and are encouraged to share the learned content with family members to reinforce responsibility and engagement. Evaluation: Continuous follow-up and assessment of learning after each session to ensure understanding and active participation.
Receives: Behavioral: Child-Centered Empowerment Intervention
Routine CareNo interventionParticipants in this group continue with their usual oncology care and do not receive any additional empowerment training. Routine medical and nursing care is delivered according to standard clinical practice without structured behavioral interventions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Lifestyle Scores

    The primary outcome measure evaluates changes in the lifestyle of children with leukemia. Lifestyle is assessed using a validated lifestyle questionnaire covering five domains: nutrition, sleep, physical activity, physical health, and stress. The tool includes 38 items rated on a 4-point Likert scale ("often" to "never"), with higher scores indicating a more favorable lifestyle.

    Measured: Lifestyle scores are measured at two time points - baseline (before the intervention) and one month after completion of the empowerment program

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Sep 2025
  2. Study start2 Sep 2024
  3. Primary completion10 Sep 2024
  4. Study completion30 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants in this clinical trial were randomly assigned to one of two groups: an experimental group receiving the child-centered empowerment intervention and a control group receiving routine pediatric oncology care. Both groups were followed in parallel throughout the study duration.
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
46 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07162558
Sponsor's protocol ID
PVF2025CAM004
Acronym
lifestyle
Status last verified
Aug 2025
First submitted
31 Aug 2025
Last updated
9 Sep 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: There is no plan to make IPD available to other researchers

Questions about this trial

What is this clinical trial studying?

A study testing Child-Centered Empowerment Intervention in people with Leukemia Acute Lymphoid Leukemia (ALL) and Lifestyle Intervention for at Least 1 Month, run by Near East University, Turkey at 1 site in Cyprus.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Cyprus. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Lifestyle Scores (time frame: Lifestyle scores are measured at two time points - baseline (before the intervention) and one month after completion of the empowerment program). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in